Related Experiment Videos
[Mitral valve disease and atrial natriuretic polypeptide]
1Department of Thoracic Surgery, School of Medicine, Nagoya University, Japan.
Nihon Geka Gakkai Zasshi
|July 1, 1987
Summary
Patients undergoing mitral valve replacement (MVR) surgery exhibit higher plasma levels of atrial natriuretic peptide (ANP) preoperatively. This suggests ANP plays a key role in regulating blood volume under conditions of left atrial pressure.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Atrial natriuretic peptide (ANP) is a hormone involved in fluid and electrolyte balance.
- Left atrial pressure can influence ANP secretion.
- Understanding ANP dynamics is crucial for managing patients undergoing cardiac surgery.
Purpose of the Study:
- To compare plasma ANP concentrations and atrial ANP content between patients undergoing mitral valve replacement (MVR) and a control group.
- To investigate the relationship between ANP levels, other fluid-regulating hormones, and renal function during open heart surgery.
Main Methods:
- Plasma levels of ANP, ADH, and ACTH were measured.
- Atrial tissue concentration of ANP was determined.
- Renal function was assessed.
- Comparisons were made between the MVR group (n=12) and the non-MVR group (n=14).
Main Results:
- Preoperatively, plasma ANP was significantly higher in the MVR group (96.9 pg/ml) compared to the non-MVR group (22.8 pg/ml).
- During extracorporeal circulation, ANP levels decreased due to aortic clamping.
- Atrial ANP content was significantly higher in both right and left appendages of the MVR group compared to the non-MVR group.
Conclusions:
- Elevated left atrial pressure, as seen in MVR patients, likely triggers increased ANP secretion.
- ANP plays a significant role in the regulation of circulating blood volume, particularly in response to atrial loading conditions.